ArticleActa neuropathologica2022
The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers.
Nazanin Tatari et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it